SMARCA4 and small cell lung carcinoma: Although histologic evaluation was limited by crush artifact, cytomorphologic and immunophenotypic features were consistent with SCLC, showing TTF1 expression and no consistent loss of SMARCA4 positivity by immunohistochemistry.